Initial link of pathogenesis
The development of such a severe condition as coma hypoglycaemicum begins with a clearly defined initial link. The foundation of the pathological process is hypoglycemia itself, which occurs in mandatory combination with reduced oxygen consumption by brain neurons. Nervous tissue is critically dependent on a continuous supply of nutrients and adequate oxygenation.
When this process is disrupted, a sharp inhibition of ATP resynthesis occurs within neurons. The decrease in energy molecule production naturally generates a pronounced energy deficit in brain cells. The body cannot ignore such a massive threat to the central nervous system, so in response to the energy shortage, an emergency activation of the sympathoadrenal system takes place. This is the key moment that moves pathogenesis to the next stage.
Dual role of hypercatecholaminemia
Activation of the sympathoadrenal system leads to a state of hypercatecholaminemia, which performs two fundamentally different yet equally important functions in the body.
- Protective function. A massive release of catecholamines is necessary to brake the development of severe, irreversible hypoglycemia. The main mechanism of this protection is the stimulation of glycogenolysis—the process of breaking down glycogen stores to release free glucose.
- Clinical manifestations. It is precisely because of the high level of catecholamines that the patient experiences cardiac arrhythmias, marked muscle weakness, and a number of other characteristic symptoms. From a clinical standpoint, these signs act as a kind of "alarm": they are subjectively felt by the patient and prompt them to urgently take dextrose (glucose) to stop the attack.
Complex of disorders in neuronal energy deficit
If protective mechanisms fail and the patient does not take dextrose, the consequences of impaired neuronal energy supply become catastrophic. A severe complex of neurological and somatic disorders develops.
- Changes in higher nervous activity (HNA). This process unfolds in stages: the patient develops progressive drowsiness, speech disorders, and severe headache. As energy starvation deepens, confusion sets in, ultimately ending in a complete loss of consciousness.
- Development of seizures. Following the depression of HNA, the pathological process engulfs the motor centers.
- Circulatory failure (CF). At the final stages of coma, vital centers suffer. This leads to central and organ-tissue vascular disorders, up to the development of profound collapse.
- Respiratory failure (RF). Concurrently, an acute oxygen shortage forms, culminating in the cessation of breathing—apnea.
Long-term metabolic consequences: angiopathies
When considering acute metabolic catastrophes, one must also remember the long-term consequences of metabolic disorders in diabetes mellitus (DM). The basis of the pathogenesis of these chronic complications is also profound metabolic disorders in various organs and tissues.
One of the main manifestations of such disorders is diabetic angiopathy. The timing of their appearance is quite predictable: vascular lesions usually manifest 10–15 years after the onset of diabetes mellitus, although in some cases they can develop much earlier.
Modern classification of diabetic angiopathies distinguishes two main forms:
- Microangiopathies — damage to small blood vessels.
- Macroangiopathies — involvement of large vascular trunks in the pathological process.
Briefly: answers to topical questions
Which hormones, besides catecholamines, are counter-regulatory and counteract hypoglycemia?
In addition to catecholamines, sources indicate the following as counter-regulatory/hyperglycemic hormones:
- Glucagon.
- Glucocorticoids, including cortisol.
- Iodothyronines — thyroid hormones.
- Growth hormone — GH.
- Adrenocorticotropic hormone — ACTH.
For the fasting state, the source indicates that the release of glucagon, GH, cortisol, and adrenaline prevents blood sugar from dropping critically by triggering glycogenolysis, gluconeogenesis, and lipolysis.
At what blood glucose level do the first clinical signs of hypoglycemia typically appear?
The cited sources do not specify the level at which "the first clinical signs typically appear" of hypoglycemia.
The following thresholds are indicated:
- measures to correct hypoglycemia should be initiated at a plasma glucose level of < 3.9 mmol/L;
- Level 1: plasma glucose from 3.0 to < 3.9 mmol/L, may present with or without symptoms;
- Level 2: plasma glucose < 3.0 mmol/L, clinically significant hypoglycemia requiring immediate correction;
- Level 3: severe hypoglycemia defined by impaired cognitive function, including loss of consciousness/coma, and the need for assistance from another person; specific glucose threshold not specified.
What are the differential diagnostic distinctions between hypoglycemic and ketoacidotic coma?
Differential diagnosis between hypoglycemic and diabetic (ketoacidotic) coma is based on clinical and laboratory manifestations.
| Sign | Hypoglycemic coma | Ketoacidotic coma |
|---|---|---|
| Prodromal signs | Hunger | Severe thirst, polyuria |
| Skin | Marked diaphoresis (moist skin) | Dry skin |
| Blood | Decreased glucose level | Sharp increase in glucose level, ketonemia |
| Urine | Absence of glucose and acetone | Ketonuria |
To memorize the consequences of cerebral energy deficit, use the "top-down" rule: the cortex suffers first (HNA: drowsiness, speech disorders, confusion), then the subcortex (seizures), and finally the brainstem centers (collapse and apnea).
Class and exam questions
What is the role of hypercatecholaminemia in the pathogenesis of hypoglycemic states?
Hypercatecholaminemia plays a dual role. On the one hand, it provides a protective function by stimulating glycogenolysis and preventing the development of severe hypoglycemia. On the other hand, it triggers clinical manifestations (cardiac arrhythmias, muscle weakness) that signal the patient to urgently ingest dextrose.
What changes in higher nervous activity precede complete loss of consciousness?
Disorders of higher nervous activity develop gradually against the background of a mounting energy deficit. Patients experience progressive drowsiness, headache, speech disorders, and confusion, ultimately leading to coma.
What fatal consequences are caused by impaired neuronal energy supply?
In addition to loss of consciousness and seizures, a critical ATP deficit causes circulatory failure (central and organ-tissue types up to collapse), as well as acute respiratory failure, which can end in apnea.
How long after the onset of diabetes mellitus do angiopathies typically develop?
As a rule, diabetic angiopathies (microangiopathies and macroangiopathies), which are based on chronic metabolic disorders in organs and tissues, appear 10–15 years after the onset of the disease, although sometimes this process begins earlier.
What else to study on this topic
- Mechanisms of ATP resynthesis inhibition in nervous tissue during hypoglycemia and hypoxia.
- The process of glycogenolysis as a protective reaction to hypercatecholaminemia.
- Pathogenesis of central and organ-tissue circulatory failure in coma.
- The relationship between metabolic disorders and the development of micro- and macroangiopathies.
- Stages of higher nervous activity depression with escalating energy deficiency.
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Hypoglycemic coma" and 4,913 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 135 video lessons on the subject
Other topics in "Chapter 8. Disorders of Carbohydrate Metabolism"
Free video lessons: pathophysiologyShort lessons with lecture notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.